Top Markets
#1 Black Phoenix Black Phoenix +827.96%
#2 Not in Employment, Education, or Training Not in Employment, Education, or Training +26.72%
#3 FGRS (Figure Tokenized Stock) FGRS (Figure Tokenized Stock) +25.63%
#4 pipedog pipedog +22.83%
#5 Bless Bless +22.61%
#6 SAFEcoin SAFEcoin +21.43%
#7 Beam Beam +20.30%
#8 Magma Finance Magma Finance +19.68%
#9 PondCoin PondCoin +18.61%
#10 YFSX YFSX +16.00%
Coin of the day
Black Phoenix Black Phoenix
Settings
Language
ENGLISH
Currency
USD
Theme
Zenas BioPharma, Inc. Zenas BioPharma, Inc.

Zenas BioPharma, Inc.

ZBIO
Rank in Stocks #6395
Zenas BioPharma, Inc. functions as a clinical-stage biopharmaceutical firm,... Zenas BioPharma, Inc. functions as a clinical-stage biopharmaceutical firm, concentrating on the creation and market introduction of innovative, immunology-based treatments. The company's primary investigational therapy is obexelimab, a distinctive bifunctional monoclonal antibody intended to address multiple diseases such as immunoglobulin G4-related disease, multiple sclerosis, systemic lupus erythematosus, and warm autoimmune hemolytic anemia. Its developmental portfolio also features ZB002, an anti-TNFa monoclonal antibody; ZB004, a cytotoxic T-lymphocyte-associated antigen 4-immunoglobulin fusion; ZB001, an anti-insulin-like growth factor-1 receptor monoclonal antibody; and ZB005, an anti-active complement component 1s monoclonal antibody. Established in 2019, the entity was formerly recognized as Zenas BioPharma (Cayman) Limited before adopting its current name, Zenas BioPharma, Inc., in August 2023. Its headquarters are located in Waltham, Massachusetts.
Share Price
$32.88
Market Cap
$2.08B
Change (1 day)
-0.48%
Change (1 year)
96.77%
Country
US
Trade Zenas BioPharma, Inc. (ZBIO)

Category

Healthcare
Stock price history for Zenas BioPharma, Inc. (ZBIO)
Highest end of day price: $31.74 on 2026-08-01

Lowest end of day price: $17.96 on 2024-09-01
Stock price history of Zenas BioPharma, Inc. from 2024 to 2026
Annual Stock Price Performance
Year Performance
2026 (TTM) -33.58%
2025 294.97%
2024 0.00%
Stock price for similar companies or competitors
Company Stock price Change 1y% Country
Vertex Pharmaceuticals Incorporated Vertex Pharmaceuticals Incorporated
Vertex Pharmaceuticals Incorporated
VRTX.US
 $548.48 40.97%
US
Argenx SE Argenx SE
Argenx SE
ARGX.US
 $1.06K 49.38%
NL
CSL Limited CSL Limited
CSL Limited
CSL.AX
 $122.63 -12.65%
AU
Moderna, Inc. Moderna, Inc.
Moderna, Inc.
MRNA.US
 $140.50 459.76%
US
Lonza Group AG Lonza Group AG
Lonza Group AG
LONN.SW
 $765.25 7.19%
CH